Business Standard

Russia's Sputnik V developers call on AstraZeneca to try combining vaccines

Russia said its Sputnik V vaccine is 92% effective at protecting people from COVID-19, according to interim trial results

Photo: Reuters
Premium

AstraZeneca has said it will have as many as 200 million doses of its vaccine by the end of 2020 | Photo: Reuters

Reuters
Developers of the Sputnik V Covid-19 vaccine said on Thursday that AstraZeneca should try combining its experimental shot with the Russian one to boost efficacy.
 
Russia said its Sputnik V vaccine is 92% effective at protecting people from Covid-19, according to interim trial results, while AstraZeneca said its Covid-19 vaccine was 70% effective in pivotal trials and could be up to 90% effective.
 
"If they go for a new clinical trial, we suggest trying a regimen of combining the AZ shot with the #SputnikV human adenoviral vector shot to boost efficacy," the developers of the Russian vaccine said on their

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 27 2020 | 12:53 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com